1.
The impact of the SARS-CoV-2 outbreak on the safety and availability of blood transfusions in Italy.
Vox Sang
; 115(8): 603-605, 2020 11.
Article
in English
| MEDLINE | ID: covidwho-1388424
Subject(s)
COVID-19 , Coronavirus , Blood Safety , Blood Transfusion , Disease Outbreaks , Humans , Italy/epidemiology , SARS-CoV-2
2.
Transfus Med Hemother
; 48(2): 132-133, 2021 Mar.
Article
in English
| MEDLINE | ID: covidwho-1314189
3.
Transfus Med
; 31(3): 215-216, 2021 Jun.
Article
in English
| MEDLINE | ID: covidwho-1273134
4.
Int J Infect Dis
; 102: 244-246, 2021 Jan.
Article
in English
| MEDLINE | ID: covidwho-1059790
ABSTRACT
COVID-19 convalescent plasma (CCP) is widely used as a treatment. While safety data are enough, high-level evidences of efficacy are still missing. We summarize here the results from randomized controlled trials (RCT) published to date and analyze their flaws and biases. We then provide suggestions for next round of CCP RCTs, discussing specification of CCP, therapeutic dose, timing, control arm, disease stage, and outcome measures.
Subject(s)
COVID-19/therapy , Randomized Controlled Trials as Topic , SARS-CoV-2 , Humans , Immunization, Passive , Outcome Assessment, Health Care , COVID-19 Serotherapy
5.
Transfusion
; 60(7): 1644-1646, 2020 07.
Article
in English
| MEDLINE | ID: covidwho-597813